MedTrace Logo

Real-life Evaluation of the Daivobet® Gel Applicator

NCT02856542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1560

Last updated 2017-10-19

No results posted yet for this study

Summary

This study aims to describe the patient population being treated and evaluate their treatment adherence and treatment outcomes during treatment of scalp psoriasis with Daivobet® gel Applicator for 4 weeks.

Conditions

Interventions

DRUG

calcipotriol/betamethasone dipropionate gel in Applicator

Topical treatment of scalp using applicator device. The study as such is non-interventional as the intervention has been decided prior to and independently from the inclusion of the patient in the cohort to be observed.

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Mathilde Kemula, MD · Cabinet de Dermatologie, Dr. Mathilde Kemula

  • Frederic Bonnier, MD · General Practice, 356 Rue de Charles de Gaulle, 91400 Orsay

  • Nathalie Quiles, MD · Hôpital Saint Joseph, 26 Boulevard de Louvain, Marseille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-23
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02856542 on ClinicalTrials.gov